Boston Scientific to Make Debut at China International Import Expo, Unveils Innovative Medical Technologies

Shanghai, July 28, 2019 /PRNewswire/ -- With 100 days to go before the opening of the second China International Import Expo (hereinafter referred to as the "CIIE"), Boston Scientific Corporation (NYSE: BSX) announced that it will make its debut at the CIIE. The company will showcase its cutting-edge products and technologies in the field of minimally invasive interventions, as well as its significant achievements in integrating global resources, building an industry ecosystem featuring government-industry-academia-research collaboration, and promoting local innovation. Through the CIIE's global trade platform, Boston Scientific aims to bring world-leading medical solutions to more patients in China, contributing to the realization of the "Healthy China" vision.

“This is not only a showcase of innovation, but also an opportunity to foster exchange and collaboration,” said Ms. Zhang Jun, Vice President of Boston Scientific and General Manager of Greater China. “This year marks the 40th anniversary of Boston Scientific Corporation. We are fully prepared and look forward to leveraging the open and diverse platform of the China International Import Expo (CIIE) to present our four decades of innovative achievements, and to engage with peers from all sectors in discussing the cross-sector integration of new technologies, new business formats, and new models, working together to realize the grand vision of building a Healthy China.”

Continuous Innovation to Help Address Local Health Challenges

As a global leader in the field of minimally invasive interventional medicine, Boston Scientific is committed to innovation, providing patients with innovative, safe, and high-quality solutions. Leveraging its cutting-edge products and technologies, Boston Scientific has continuously climbed the ranks in Forbes’ “World’s 100 Most Innovative Companies” list, rising to 65th place in 2018. In the recently announced nominations for this year’s Galen Prize, often referred to as the “Nobel Prize of the pharmaceutical industry,” three of Boston Scientific’s products and technologies in the fields of heart failure detection, embolic protection, and digestive endoscopy were nominated for “Best Medical Technology,” making it the company with the most nominations in this category. Boston Scientific will also showcase its outstanding solutions at the China International Import Expo (CIIE), fully demonstrating its internationally leading R&D capabilities and the innovative vitality of being “forty and in its prime.”

Since entering China in 1997, Boston Scientific has upheld its mission of “Innovating for Life,” continuously introducing cutting-edge global medical solutions to address the needs of Chinese patients and help local healthcare professionals enhance their specialized skills. Its R&D center, open innovation platform, and Innovation Training Institute have all been established in China, integrating global resources to empower local innovation and actively contributing to addressing the health challenges facing China.

Joining Hands with All Parties to Build China’s Medical Innovation Ecosystem

Boston Scientific is not only dedicated to addressing significant unmet medical needs, but also responds to China’s call for “collaborative innovation among government, industry, academia, and research” as the healthcare industry enters a new cycle driven by innovation and transformative change. By deeply engaging with local partners across the entire value chain to leverage complementary strengths, Boston Scientific is building a comprehensive and vibrant ecosystem for medical technology innovation. Furthermore, the company has established an open, diverse, and integrated Asia-Pacific innovation platform that combines cutting-edge global technologies and R&D capabilities with local market expertise, jointly accelerating medical innovation in China and leading future innovative transformations in the industry and business landscape.

At this year’s China International Import Expo, Boston Scientific cordially invites like-minded partners from all sectors of society to leverage their respective strengths, co-create for mutual success, explore innovative integration in the field of medical technology, facilitate the decentralization of high-quality medical resources, and promote the prosperous development of the healthcare ecosystem, with the aim of jointly building and sharing a Healthy China.

“Love Without Borders” Philosophy “Waves” Care

As a leading enterprise in the medical technology sector, Boston Scientific is not only committed to “Innovating for Life” but also consistently upholds a “Heart of Care” and the philosophy of “Boundless Innovation, Limitless Love,” sparing no effort to fulfill its social responsibilities. With “employee well-being first” as its goal, Boston Scientific cares deeply about every employee’s career development and family happiness, implementing a rich array of employee care programs and earning the “2019 Top Employers China” certification. Furthermore, by championing the “Borderless Volunteers” concept, Boston Scientific collaborates with employees, healthcare professionals, partners, and other stakeholders to jointly support science popularization education for adolescents and strengthen primary healthcare capacity, generating positive and widespread social impact. In recognition of these efforts, the company has been honored with awards such as the “Top 10 Health Public Welfare Brands of Healthy China 2018.”